Search Within

Robert T Heelan

Formats
  1. Journal Article (118)
  2. Meeting Abstract (16)
  3. Conference Paper (4)
  4. Book Section (2)
Groups
  1. Department of Medicine (97)
  2. Solid Tumor Oncology Division (94)
  3. Thoracic Oncology (62)
  4. Surgery (41)
  5. Center for Pancreatic Cancer Research (33)
  6. Survivorship Research (28)

More Groups

People
  1. Mark Kris (62)
  2. Vincent Miller (37)
  3. David Kelsen (25)
  4. Valerie Rusch (20)
  5. Lee Krug (19)
  6. Richard Gralla (19)

More People

Years
  1. 2019 (1)
  2. 2015 (1)
  3. 2011 (2)
  4. 2010 (1)
  5. 2009 (1)
  6. 2008 (2)

More Years

Publications
  1. Journal of Clinical Oncology (27)
  2. Cancer (13)
  3. Cancer Treatment Reports (11)
  4. Radiology (9)
  5. Journal of Thoracic and Cardiovascular Surgery (8)
  6. American Journal of Clinical Oncology (5)

More Publications

Publishers
  1. American Society of Clinical Oncology (27)
  2. Wiley Blackwell (13)
  3. National Cancer Institute (11)
  4. American Association for Cancer Research (10)
  5. Elsevier Inc. (9)
  6. Lippincott Williams & Wilkins (9)

More Publishers

Results (140)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • CT screening for lung cancer: Comparison of three baseline screening protocols
    Journal Article

    Henschke, C. I.; Yip, R.; Ma, T.; Aguayo, S. M.; Zulueta, J.; Yankelevitz, D. F.; Writing Committee for the I-ELCAP Investigators
    European Radiology (2019)

    Fulltext@MSK | Save
  • A comparison of the pathological, clinical and radiographical, features of cryptogenic organising pneumonia, acute fibrinous and organising pneumonia and granulomatous organising pneumonia
    Journal Article

    Feinstein, M. B.; Desouza, S. A.; Moreira, A. L.; Stover, D. E.; Heelan, R. T.; Iyriboz, T. A.; Taur, Y.; Travis, W. D.
    Journal of Clinical Pathology (2015)

    Fulltext@MSK | Save
  • A phase 2 study of weekly albumin-bound paclitaxel (Abraxane ®) given as a two-hour infusion
    Journal Article

    Paik, P. K.; James, L. P.; Riely, G. J.; Azzoli, C. G.; Miller, V. A.; Ng, K. K.; Sima, C. S.; Heelan, R. T.; Kris, M. G.; Moore, E.; more...
    Cancer Chemotherapy and Pharmacology (2011)

    Fulltext@MSK | Save
  • Molecular characteristics predict clinical outcomes: Prospective trial correlating response to the EGFR tyrosine kinase inhibitor gefitinib with the presence of sensitizing mutations in the tyrosine binding domain of the EGFR gene
    Journal Article

    Rizvi, N. A.; Rusch, V.; Pao, W.; Chaft, J. E.; Ladanyi, M.; Miller, V. A.; Krug, L. M.; Azzoli, C. G.; Bains, M.; Downey, R.; more...
    Clinical Cancer Research (2011)

    Fulltext@MSK | Save
  • Phase II trial of gefitinib and everolimus in advanced non-small cell lung cancer
    Journal Article

    Price, K. A.; Azzoli, C. G.; Krug, L. M.; Pietanza, M. C.; Rizvi, N. A.; Pao, W.; Kris, M. G.; Riely, G. J.; Heelan, R. T.; Arcila, M. E.; more...
    Journal of Thoracic Oncology (2010)

    Fulltext@MSK | Save
  • Morphologic features of adenocarcinoma of the lung predictive of response to the epidermal growth factor receptor kinase inhibitors erlotinib and gefitinib
    Journal Article

    Zakowski, M. F.; Hussain, S.; Pao, W.; Ladanyi, M.; Ginsberg, M. S.; Heelan, R.; Miller, V. A.; Rusch, V. W.; Kris, M. G.
    Archives of Pathology & Laboratory Medicine (2009)

    Fulltext@MSK | Save
  • Phase I/II trial of weekly intravenous 130-nm albumin-bound paclitaxel as initial chemotherapy in patients with stage IV non-small-cell lung cancer
    Journal Article

    Rizvi, N. A.; Riely, G. J.; Azzoli, C. G.; Miller, V. A.; Ng, K. K.; Fiore, J.; Chia, G.; Brower, M.; Heelan, R.; Hawkins, M. J.; more...
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Molecular characteristics of bronchioloalveolar carcinoma and adenocarcinoma, bronchioloalveolar carcinoma subtype, predict response to erlotinib
    Journal Article

    Miller, V. A.; Riely, G. J.; Zakowski, M. F.; Li, A. R.; Patel, J. D.; Heelan, R. T.; Kris, M. G.; Sandler, A. B.; Carbone, D. P.; Tsao, A.; more...
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • A phase II study to determine if sensory neuropathy of nab-paclitaxel can be reduced by prolonging infusion in patients with non-small cell lung cancer (NSCLC)
    Meeting Abstract

    James, L. P.; Kris, M. G.; Heelan, R. T.; Ng, K. K.; Chia, G. H.; Gomez, J. E.; Krug, L. M.; Moore, E.; Hawkins, M. J.; Rizvi, N. A.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Prospective trial of preoperative gefitinib to correlate response with EGFR exon 19 and 21 mutations and to select patients for adjuvant gefitinib
    Meeting Abstract

    Kris, M. G.; Pao, W.; Zakowski, Maureen F; Ladanyi, M.; Heelan, R. T.; Schwartz, L.; Zhao, B.; Venkatraman, E.; Rusch, V.; Rizvi, N. A.
    Journal of Thoracic Oncology (2007)

    Fulltext@MSK | Save